Skip to main content

Table 1 Patient characteristics at enrolment to the study

From: Determinants of time to antiretroviral treatment initiation and subsequent mortality on treatment in a cohort in rural northern Malawi

Total—n

617

Registered within KHDSS—n (%)

566 (92)

Route of HIV testing—n (%)

  CRH

275 (45)

  HIV serosurvey

277 (45)

  Missing

65 (11)

 Sex—n (%)

  Male

248 (40)

  Female

369 (60)

 Age—n (%)

  15–34

257 (42)

  ≥35

360 (58)

  Median age—years

37.0

 Weight—kg

  Median (IQR)

52.6 (47.8–59.0)

  Median BMI

20.2

 Year—n (%)

  2008

227 (37)

  2009

175 (28)

  2010

148 (24)

  2011

67 (11)

 WHO stage—n (%)

  I

122 (20)

  II

251 (41)

  III

196 (32)

  IV

48 (8)

 CD4 count—n (%)

  ≤250 cells/μL

315 (51)

  251–350 cells/μL

93 (15)

  351–500 cells/μL

85 (14)

  >500 cells/μL

109 (18)

  Missing

15 (2)

 Median CD4 count—cells/μL (IQR)

  Overall

239 (122–420)

 By sex

  Male

188 (89–345)

  Female

273 (152–466)

 By route of HIV testing

  CRH

187 (85–382)

  HIV serosurvey

277 (156–468)

  Missing

240 (127–404)